top of page
Search

C.H. Robinson

Writer: Abacus Research
Abacus Research
Dec 17, 2025
1 min read

CHRW has been going through significant change, They are retaking market share.

The new CEO has transformed the company by bringing in a lean / AI, that has helped CHRW to grow earnings despite struggling topline.


  • Even without any help from a cyclical recovery, we expect EPS growth for the next three years to average ~19%.

  • Demand environment highly unlikely to get worse without a severe recession, hence any cyclical upside mostly a free option.

  • We are interested in CHRW because we believe it can take share and because has shown high operating leverage with incremental margins of ~100%.


Potential Upside:     $212 (+32%)

Sensible Downside: $127(-20%)


 
 
 

Recent Posts

See All
GOOGL, AMZN: Plays on inference and bundling

We see the power moving back towards the Hyperscalers, and find the combination of less risk, high growth and reasonable valuations to be compelling. AMZN: sensible upside to $305 (+20%) SOTP model an

 
 
 
RYAN / Insurance Cycle

Ryan (RYAN) is a typical hard market beneficiary, that is going through an organic growth reset. Are we there yet in terms of the reset- probably not. Timing the bottom of a cyclical market is hard. N

 
 
 

Comments

bottom of page